インドのワクチン市場規模、シェア、動向分析レポート：セグメント予測、2025‐2033

レポートナンバー　0000042531

医薬品原料・製剤

インドのワクチン市場規模、シェア、動向分析レポート：セグメント予測、2025‐2033

Grand View Research Inc.

India Vaccine Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2025- 2033

発刊日 2025/09

言語英語

体裁PDF/150ページ

ライセンス/価格150ページ

0000042531

Individual	3,950USD
Team	4,950USD
Enterprise	6,950USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

インドのワクチン市場規模、シェア、動向分析レポート:適応症別 (ウイルスワクチン、細菌ワクチン、がんワクチン)、タイプ別、投与経路別 (経口、非経口、経鼻)、年齢層別、流通チャネル別、およびセグメント予測、2025 -2033

インドのワクチン市場規模と動向

インドのワクチン市場は、2024年に24億5,000万ドルと推定され、2025年から2033年にかけて8.50%のCAGRで成長し2033年までに52億ドルに達すると予測されます。この成長は、結核、肝炎、肺炎、インフルエンザなどの感染症の負担が大きいことによって推進されており、効果的なワクチン接種プログラムの必要性が浮き彫りになっています。たとえば、2025 年 6 月、世界保健機関は、2022 年にインドで約 2,980 万人が HBV 感染症を患っており、これは肝硬変の第 3 位の原因であり、約 98,305 人が死亡したと報告しました。

レポート詳細

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Indication
1.2.2. Type
1.2.3. Route of Administration
1.2.4. Age Group
1.2.5. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Source
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Source
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. India Vaccine Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis

Chapter 4. India Vaccine Market: Indication Business Analysis
4.1. Indication Market Share, 2024 & 2033
4.2. Indication Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2021 to 2033 (USD Billion)
4.4. Viral Vaccines
4.4.1. Viral Vaccines Market, 2021 - 2033 (USD Billion)
4.4.2. Hepatitis
4.4.2.1. Hepatitis Market, 2021 - 2033 (USD Billion)
4.4.2.2. Pediatric (Children)
4.4.2.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.4.2.3. Adult
4.4.2.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.4.3. Influenza
4.4.3.1. Influenza Market, 2021 - 2033 (USD Billion)
4.4.3.2. Pediatric (Children)
4.4.3.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.4.3.3. Adult
4.4.3.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.4.4. HPV
4.4.4.1. HPV Market, 2021 - 2033 (USD Billion)
4.4.4.2. Pediatric (Children)
4.4.4.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.4.4.3. Adult
4.4.4.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.4.5. MMR
4.4.5.1. MMR Market, 2021 - 2033 (USD Billion)
4.4.5.2. Pediatric (Children)
4.4.5.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.4.5.3. Adult
4.4.5.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.4.6. Rotavirus
4.4.6.1. Rotavirus Market, 2021 - 2033 (USD Billion)
4.4.6.2. Pediatric (Children)
4.4.6.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.4.6.3. Adult
4.4.6.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.4.7. Herpes Zoster
4.4.7.1. Herpes Zoster Market, 2021 - 2033 (USD Billion)
4.4.7.2. Pediatric (Children)
4.4.7.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.4.7.3. Adult
4.4.7.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.4.8. Japanese Encephalitis
4.4.8.1. Japanese Encephalitis Market, 2021 - 2033 (USD Billion)
4.4.8.2. Pediatric (Children)
4.4.8.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.4.8.3. Adult
4.4.8.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.4.9. RSV
4.4.9.1. RSV Market, 2021 - 2033 (USD Billion)
4.4.9.2. Pediatric (Children)
4.4.9.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.4.9.3. Adult
4.4.9.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.4.10. Others Viral Vaccines
4.4.10.1. Others Viral Vaccines Market, 2021 - 2033 (USD Billion)
4.4.10.2. Pediatric (Children)
4.4.10.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.4.10.3. Adult
4.4.10.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.5. Bacterial Vaccines
4.5.1. Bacterial Vaccines Market, 2021 - 2033 (USD Billion)
4.5.2. Meningococcal Diseases
4.5.2.1. Meningococcal Diseases Market, 2021 - 2033 (USD Billion)
4.5.2.2. Pediatric (Children)
4.5.2.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.5.2.3. Adult
4.5.2.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.5.3. Pneumococcal diseases
4.5.3.1. Pneumococcal diseases Market, 2021 - 2033 (USD Billion)
4.5.3.2. Pediatric (Children)
4.5.3.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.5.3.3. Adult
4.5.3.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.5.4. DPT
4.5.4.1. DPT Market, 2021 - 2033 (USD Billion)
4.5.4.2. Pediatric (Children)
4.5.4.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.5.4.3. Adult
4.5.4.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.5.5. Others Bacterial Vaccines
4.5.5.1. Others Bacterial Vaccines Market, 2021 - 2033 (USD Billion)
4.5.5.2. Pediatric (Children)
4.5.5.2.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.5.5.3. Adult
4.5.5.3.1. Adult Market, 2021 - 2033 (USD Billion)
4.6. Cancer Vaccines
4.6.1. Cancer Vaccines Market, 2021 - 2033 (USD Billion)
4.6.1.1. Pediatric (Children)
4.6.1.1.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.6.1.2. Adult
4.6.1.2.1. Adult Market, 2021 - 2033 (USD Billion)
4.7. Allergy Vaccines
4.7.1. Allergy Vaccines Market, 2021 - 2033 (USD Billion)
4.7.1.1. Pediatric (Children)
4.7.1.1.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.7.1.2. Adult
4.7.1.2.1. Adult Market, 2021 - 2033 (USD Billion)
4.8. Other Indication
4.8.1. Other Indication Market, 2021 - 2033 (USD Billion)
4.8.1.1. Pediatric (Children)
4.8.1.1.1. Pediatric (Children) Market, 2021 - 2033 (USD Billion)
4.8.1.2. Adult
4.8.1.2.1. Adult Market, 2021 - 2033 (USD Billion)

Chapter 5. India Vaccine Market: Type Business Analysis
5.1. Type Market Share, 2024 & 2033
5.2. Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Billion)
5.4. Subunit Vaccines
5.4.1. Subunit Vaccines Market, 2021 - 2033 (USD Billion)
5.4.1.1. Recombinant Vaccines
5.4.1.1.1. Recombinant Vaccines Market, 2021 - 2033 (USD Billion)
5.4.1.2. Conjugate Vaccines
5.4.1.2.1. Conjugate Vaccines Market, 2021 - 2033 (USD Billion)
5.4.1.3. Toxoid Vaccines
5.4.1.3.1. Toxoid Vaccines Market, 2021 - 2033 (USD Billion)
5.5. Inactivated
5.5.1. Inactivated Market, 2021 - 2033 (USD Billion)
5.6. Live Attenuated
5.6.1. Live Attenuated Market, 2021 - 2033 (USD Billion)
5.7. mRNA Vaccines
5.7.1. mRNA Vaccines Market, 2021 - 2033 (USD Billion)
5.8. Viral Vector Vaccines
5.8.1. Viral Vector Vaccines Market, 2021 - 2033 (USD Billion)

Chapter 6. India Vaccine Market: Route of Administration Business Analysis
6.1. Route of Administration Market Share, 2024 & 2033
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Billion)
6.4. Oral
6.4.1. Oral Market, 2021 - 2033 (USD Billion)
6.5. Parenteral
6.5.1. Parenteral Market, 2021 - 2033 (USD Billion)
6.6. Nasal
6.6.1. Nasal Market, 2021 - 2033 (USD Billion)

Chapter 7. India Vaccine Market: Age Group Business Analysis
7.1. Age Group Market Share, 2024 & 2033
7.2. Age Group Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Age Group, 2021 to 2033 (USD Billion)
7.4. Pediatric Age Group
7.4.1. Pediatric Age Group Market, 2021 - 2033 (USD Billion)
7.5. Adult Age Group
7.5.1. Adult Age Group Market, 2021 - 2033 (USD Billion)

Chapter 8. India Vaccine Market: Distribution Channel Business Analysis
8.1. Distribution Channel Market Share, 2024 & 2033
8.2. Distribution Channel Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Billion)
8.4. Hospital & Retail Pharmacies
8.4.1. Hospital & Retail Pharmacies Market, 2021 - 2033 (USD Billion)
8.5. Government Suppliers
8.5.1. Government Suppliers Market, 2021 - 2033 (USD Billion)
8.6. Others
8.6.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. Moderna Inc
9.5.1.1. Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. BioNTech SE ADR
9.5.2.1. Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. CSL Ltd
9.5.3.1. Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. Sinovac Biotech Ltd
9.5.4.1. Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. AstraZeneca PLC
9.5.5.1. Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. Serum Institute of India Pvt. Ltd.
9.5.6.1. Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. GSK PLC
9.5.7.1. Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. Merck & Co Inc
9.5.8.1. Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 India vaccine market, by Indication, 2021 - 2033 (USD Billion)
Table 4 India vaccine market, by Type, 2021 - 2033 (USD Billion)
Table 5 India vaccine market, by Route of Administration, 2021 - 2033 (USD Billion)
Table 6 India vaccine market, by Age Group, 2021 - 2033 (USD Billion)
Table 7 India vaccine market, by Distribution Channel, 2021 - 2033 (USD Billion)

List of Figures
Fig. 1 India vaccine market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape
Fig. 10 India vaccine market dynamics
Fig. 11 India vaccine market: Porter’s five forces analysis
Fig. 12 India vaccine market: PESTLE analysis
Fig. 13 Indication market, 2021 - 2033 (USD Billion)
Fig. 14 Viral Vaccines market, 2021 - 2033 (USD Billion)
Fig. 15 Hepatitis market, 2021 - 2033 (USD Billion)
Fig. 16 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 17 Adult market, 2021 - 2033 (USD Billion)
Fig. 18 Influenza market, 2021 - 2033 (USD Billion)
Fig. 19 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 20 Adult market, 2021 - 2033 (USD Billion)
Fig. 21 HPV market, 2021 - 2033 (USD Billion)
Fig. 22 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 23 Adult market, 2021 - 2033 (USD Billion)
Fig. 24 MMR market, 2021 - 2033 (USD Billion)
Fig. 25 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 26 Adult market, 2021 - 2033 (USD Billion)
Fig. 27 Rotavirus market, 2021 - 2033 (USD Billion)
Fig. 28 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 29 Adult market, 2021 - 2033 (USD Billion)
Fig. 30 Herpes Zoster market, 2021 - 2033 (USD Billion)
Fig. 31 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 32 Adult market, 2021 - 2033 (USD Billion)
Fig. 33 Japanese Encephalitis market, 2021 - 2033 (USD Billion)
Fig. 34 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 35 Adult market, 2021 - 2033 (USD Billion)
Fig. 36 RSV market, 2021 - 2033 (USD Billion)
Fig. 37 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 38 Adult market, 2021 - 2033 (USD Billion)
Fig. 39 Others Viral Vaccines market, 2021 - 2033 (USD Billion)
Fig. 40 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 41 Adult market, 2021 - 2033 (USD Billion)
Fig. 42 Bacterial Vaccines market, 2021 - 2033 (USD Billion)
Fig. 43 Meningococcal Diseases market, 2021 - 2033 (USD Billion)
Fig. 44 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 45 Adult market, 2021 - 2033 (USD Billion)
Fig. 46 Pneumococcal diseases market, 2021 - 2033 (USD Billion)
Fig. 47 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 48 Adult market, 2021 - 2033 (USD Billion)
Fig. 49 DPT market, 2021 - 2033 (USD Billion)
Fig. 50 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 51 Adult market, 2021 - 2033 (USD Billion)
Fig. 52 Others Bacterial Vaccines market, 2021 - 2033 (USD Billion)
Fig. 53 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 54 Adult market, 2021 - 2033 (USD Billion)
Fig. 55 Cancer Vaccines market, 2021 - 2033 (USD Billion)
Fig. 56 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 57 Adult market, 2021 - 2033 (USD Billion)
Fig. 58 Allergy Vaccines market, 2021 - 2033 (USD Billion)
Fig. 59 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 60 Adult market, 2021 - 2033 (USD Billion)
Fig. 61 Other Indication market, 2021 - 2033 (USD Billion)
Fig. 62 Pediatric (Children) market, 2021 - 2033 (USD Billion)
Fig. 63 Adult market, 2021 - 2033 (USD Billion)
Fig. 64 Type market, 2021 - 2033 (USD Billion)
Fig. 65 Subunit Vaccines market, 2021 - 2033 (USD Billion)
Fig. 66 Recombinant Vaccines market, 2021 - 2033 (USD Billion)
Fig. 67 Conjugate Vaccines market, 2021 - 2033 (USD Billion)
Fig. 68 Toxoid Vaccines market, 2021 - 2033 (USD Billion)
Fig. 69 Inactivated market, 2021 - 2033 (USD Billion)
Fig. 70 Live Attenuated market, 2021 - 2033 (USD Billion)
Fig. 71 mRNA Vaccines market, 2021 - 2033 (USD Billion)
Fig. 72 Viral Vector Vaccines market, 2021 - 2033 (USD Billion)
Fig. 73 Route of Administration market, 2021 - 2033 (USD Billion)
Fig. 74 Oral market, 2021 - 2033 (USD Billion)
Fig. 75 Parenteral market, 2021 - 2033 (USD Billion)
Fig. 76 Nasal market, 2021 - 2033 (USD Billion)
Fig. 77 Age Group market, 2021 - 2033 (USD Billion)
Fig. 78 Pediatric Age Group market, 2021 - 2033 (USD Billion)
Fig. 79 Adult Age Group market, 2021 - 2033 (USD Billion)
Fig. 80 Distribution Channel market, 2021 - 2033 (USD Billion)
Fig. 81 Hospital & Retail Pharmacies market, 2021 - 2033 (USD Billion)
Fig. 82 Government Suppliers market, 2021 - 2033 (USD Billion)
Fig. 83 Others Distribution Channel market, 2021 - 2033 (USD Billion)

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000042531

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。